CONCLUSION: The study identified CD180 and COA3 as candidate biomarkers for ADHD-I, which may provide new clues into the mechanism of ADHD-I and potential therapeutic targets.
CONCLUSION: The study identified CD180 and COA3 as candidate biomarkers for ADHD-I, which may provide new clues into the mechanism of ADHD-I and potential therapeutic targets.